Invitation Letter Example
Invitation Letter Example
Please use current specifications for your book (e.g., length requirements, etc.) as this is only an example.
Dear
As Editor of an Elsevier book entitled “EPIGENETICS IN HUMAN DISEASE", I would like to invite you to contribute a chapter in the subject area of “ “.
As you are probably aware, Elsevier is a major international publisher. Some of the key features that will differentiate this book from most other books on epigenetics are 1) comprehensive analysis of the epigenetics of human diseases, 2) coverage of the epigenetics of disease followed by a chapter describing the most recent advances in epigenetic approaches for treating the disease (this allows basic scientists to readily view how their efforts are currently being translated to the clinic and it also allows clinicians to review in side-by-side chapters the epigenetic basis of the diseases they are treating), 3) combination of methods and biological topics as well as basic and clinical topics, and 4) highlighting those diseases or conditions for which we have advanced knowledge such as cancer as well as those that are yielding exciting breakthroughs in epigenetics such as diabetes, neurobiological disorders and cardiovascular disease. Although I have edited prior books in epigenetics, this one will be by far the most comprehensive treatment of the epigenetics of human diseases to date.
A list of potential chapters for the book is displayed below. Multiple authors may contribute to each chapter and the working titles may be modified by authors.
The length of the text can be flexible but most of the chapters should be about 15-20 pages (~10,000 words) double-spaced. Authors’ Instructions will be sent once the volume gets underway.
I would also like to find out if you are interested in contributing to any other chapters on the list. If you or someone in your lab is not available to do this, I would be grateful if you could suggest some names (with e-mail addresses) of associates/colleagues whom you feel may be more appropriate to write this chapter.
PLEASE LET ME KNOW BY May 9, 2011 WHETHER YOU FEEL YOU MAY BE INTERESTED IN CONTRIBUTING A CHAPTER TO THIS BOOK. SUBMISSION OF THE PAPERS FOR REVIEW WOULD BE DUE BY August 1, 2011 ALTHOUGH EARLIER SUBMISSION WOULD BE ACCEPTABLE.
Thanks and I will look forward to hearing from you soon.
PROPOSED CHAPTERS:
The intended audience for this book is the vast body of students and scientists who are interested in either the underlying basis of human diseases or novel means to treat human diseases that are caused by reversible epigenetic processes. This book is intended for those with interests ranging from basic molecular biology to clinical therapy. The book should have an audience in advanced undergraduate students, graduate students, university researchers, pharmaceutical companies interested in drug development and biotechnology companies. This book could also serve as a core textbook for advanced university courses with a focus on genetic and/or human diseases. Since epigenetics has now moved to the forefront of biological sciences and this book is focused on practical aspects of this burgeoning field of science, the demand for this book should be high. The information in this book will be used as a comprehensive collection of reviews on epigenetics. Although reviews on individual topics are available in journals, this book will provide a collection of the reviews that are up-to-date, arranged in an easy to follow manner and organized into one volume. There is a need for a new book in this area not only because this field of study is exponentially advancing, but also because a comprehensive book on epigenetics of human disease with basic and clinical aspects would significantly advance this field. Each of the prior books, although excellent, has a more limited scope on human diseases than the book being proposed. The topics are vast and can be perused in the Table of Contents (see below).
EPIGENETICS IN HUMAN DISEASE
1. Epigenetics of Human Disease
Trygve O. Tollefsbol, University of Alabama at Birmingham, USA
This opening chapter will review the basics of epigenetics as it applies to human disease and will give an overview of the book and the contents of the individual chapters.
2. Methods to Determine Epigenetic Variation in Human Disease
Coverage of the leading and cutting edge methods for determining epigenetic variation in human disease.
3. DNA Methylation Alterations in Human Cancers
This chapter will cover the most recent advances in DNA methylation as it applies to cancers in humans.
4. Cancer in Humans: Histone Modifications
The intent of this chapter is to review the role of histone modifications such as acetylation, methylation, etc. in human cancers.//
29. The Role of Epigenetics in Human Aging
Although aging per se is not considered a disease, many diseases are age-related and the epigenetic aberrations of aging may contribute to these diseases.
30. Epigenetic Intervention in Human Aging
Many interventions into aging such as dietary approaches may have potential in delaying aging and its associated diseases.
We would be honored to receive a contribution from you for this volume--I look forward to your response.
Sincerely,